King Faisal Heart Institute, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
J Thorac Cardiovasc Surg. 2010 May;139(5):1189-96, 1196.e1-2. doi: 10.1016/j.jtcvs.2009.10.038. Epub 2010 Mar 11.
We examined outcomes after mitral valve replacement in children younger than 8 years.
Medical records of patients who underwent mitral valve replacement from 1990 to 2006 were reviewed. Competing-risks methodology determined time-related prevalence and associated factors for death, repeated valve replacement, and survival without reoperation.
In total, 79 patients, median age 24 months (40 days-8 years) underwent 91 mitral valve replacements (10 had repeated procedures). Underlying pathology was congenital heart disease in 95% of cases. Forty-six patients (58%) had undergone previous operations. Operative mortality was 18%, 30% for those 2-years old and younger and 6% for those older than 2 years. Competing-risks analysis showed that 10 years after initial mitral valve replacement, 40% of patients had died without repeated replacement, 20% had undergone a second replacement, and 40% remained alive without further replacement. Factors associated with death included higher prosthesis size/patient weight ratio (P < .0001) and longer crossclamp time (P < .0001). Second replacement 6 +/- 4 years after initial replacement was necessary for 10 survivors. At second replacement, larger prostheses were implanted (mean 24 mm vs 19 mm initially). Repeated MVR was associated with younger age at surgery (p = .006). Permanent pacemaker implantation was eventually needed by 11% of hospital survivors.
Mortality and repeated valve replacement are common after mitral valve replacement in children younger than 8 years, especially younger patients with significantly oversized valves. At valve reoperation, larger prostheses could be implanted, suggesting continued annular growth.
研究 8 岁以下儿童行二尖瓣置换术后的结果。
回顾 1990 年至 2006 年接受二尖瓣置换术的患者的病历。采用竞争风险方法确定与死亡、重复瓣膜置换和无再手术生存相关的时间相关发生率和相关因素。
共 79 例患者,中位年龄 24 个月(40 天至 8 岁),行 91 例二尖瓣置换术(10 例重复手术)。95%的病例为先天性心脏病。46 例(58%)患者曾接受过手术。手术死亡率为 18%,2 岁以下患者死亡率为 30%,2 岁以上患者死亡率为 6%。竞争风险分析显示,初始二尖瓣置换术后 10 年,40%的患者无重复置换死亡,20%的患者行第二次置换,40%的患者无需进一步置换仍存活。与死亡相关的因素包括较大的假体尺寸/患者体重比(P<0.0001)和较长的体外循环时间(P<0.0001)。10 例初始置换后幸存者 6±4 年需行第二次置换。第二次置换时,植入更大的假体(平均 24mm 与初始时的 19mm)。重复 MVR 与手术时年龄较小相关(p=0.006)。最终,11%的医院幸存者需要植入永久性起搏器。
8 岁以下儿童行二尖瓣置换术后死亡率和重复瓣膜置换率较高,尤其是瓣膜明显过大的年幼患者。再次瓣膜置换时,可植入更大的假体,表明环形持续生长。